US HB9886 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on September 27 2024 - 25% progression
Action: 2024-09-27 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 27 2024 - 25% progression
Action: 2024-09-27 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency.
Title
BUPE for Recovery Act Broadening Utilization of Proven and Effective Treatment for Recovery Act
Sponsors
| Rep. Paul Tonko [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-09-27 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2024-09-27 | House | Introduced in House |
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/9886/all-info |
| Text | https://www.congress.gov/118/bills/hr9886/BILLS-118hr9886ih.pdf |
